XP Chemistries Valuation Multiples

XP Chemistries is valued at $6M as of October 2026, a 48.8x revenue multiple. In the last 12 months, XP Chemistries revenue was $97K and XP Chemistries EBITDA was ($1M).

XP Chemistries Overview

About XP Chemistries

XP Chemistries AB is an inventive biotechnology company that develops and patents novel nature inspired chemical processes for the production of high-quality and sustainable natural chemicals.


Founded

2015

HQ

Sweden

Employees

3

Sectors

Financials (LTM)

Revenue: $97K
EBITDA: ($1M)

EV

$5M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

XP Chemistries Financials

XP Chemistries reported last 12-month revenue of $97K and negative EBITDA of ($1M).

In the same LTM period, XP Chemistries generated $58K in gross profit, ($1M) in EBITDA losses, and had net loss of ($1M).

Revenue (LTM)


XP Chemistries P&L

In the most recent fiscal year, XP Chemistries reported revenue of $33K and EBITDA of ($901K).

XP Chemistries is unprofitable as of last fiscal year, with gross margin of 39%, EBITDA margin of (2763%), and net margin of (2603%).

See analyst estimates for XP Chemistries
LTMLast FY202320242025202620272028
Revenue$97K$33K$70K$30K$33K
Gross Profit$58K$13K$35K$35K$13K
Gross Margin60%39%51%116%39%
EBITDA($1M)($901K)($913K)($789K)($901K)
EBITDA Margin(1115%)(2763%)(1310%)(2647%)(2763%)
EBIT Margin(1317%)(3224%)(1523%)(3144%)(3224%)
Net Profit($1M)($849K)($844K)($749K)($849K)
Net Margin(1259%)(2603%)(1211%)(2512%)(2603%)

Financial data powered by Morningstar, Inc.

XP Chemistries Stock Performance

XP Chemistries has current market cap of $6M, and enterprise value of $5M.

Market Cap Evolution


XP Chemistries' stock price is $0.02.

XP Chemistries share price decreased by 0.5% in the last 30 days, and by 29.4% in the last year.

See more trading valuation data for XP Chemistries
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$5M$6M0.0%-0.5%2.5%-29.4%$-0.00

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

XP Chemistries Valuation Multiples

XP Chemistries trades at 48.8x EV/Revenue multiple, and (4.4x) EV/EBITDA.

See NTM and 2027E valuation multiples for XP Chemistries

EV / Revenue (LTM)


XP Chemistries Financial Valuation Multiples

As of October 3, 2026, XP Chemistries has market cap of $6M and EV of $5M.

XP Chemistries has a P/E ratio of (4.7x).

LTMLast FY202320242025202620272028
EV/Revenue48.8x144.9x67.8x158.5x144.9x
EV/EBITDA(4.4x)(5.2x)(5.2x)(6.0x)(5.2x)
EV/EBIT(3.7x)(4.5x)(4.5x)(5.0x)(4.5x)
EV/Gross Profit81.0xn/m134.1x136.8xn/m
P/E(4.7x)(6.7x)(6.7x)(7.6x)(6.7x)
EV/FCF-(5.2x)(3.9x)(5.3x)(5.2x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified XP Chemistries Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

XP Chemistries Margins & Growth Rates

XP Chemistries grew revenue by 241% and EBITDA by 23% in the last fiscal year.

In the most recent fiscal year, XP Chemistries reported gross margin of 39%, EBITDA margin of (2763%), and net margin of (2603%).

See estimated margins and future growth rates for XP Chemistries

XP Chemistries Margins

Last FY202420252026202720282029
Gross Margin39%116%39%61%
EBITDA Margin(2763%)(2647%)(2763%)(994%)
EBIT Margin(3224%)(3144%)(3224%)(1179%)
Net Margin(2603%)(2512%)(2603%)(1179%)
FCF Margin(2803%)(3004%)(2803%)-

XP Chemistries Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth241%(57%)9%241%
Gross Profit Growth437%(2%)(63%)437%
EBITDA Growth23%(14%)14%23%
EBIT Growth25%(12%)12%25%
Net Profit Growth54%(11%)13%54%
FCF Growth-(25%)2%-

Data powered by FactSet, Inc. and Morningstar, Inc.

XP Chemistries Operational KPIs

XP Chemistries' revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.4M for the same period.

XP Chemistries' Rule of 40 is (753%) (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

XP Chemistries' Rule of X is (391%) (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for XP Chemistries
LTMLast FY202320242025202620272028
Rule of 401553%(753%)---
Bessemer Rule of X5556%(391%)---
Revenue per Employee-$0.0M---
Opex per Employee-$0.4M---
Opex to Revenue-3368%1573%3260%3368%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

XP Chemistries Competitors

XP Chemistries competitors include OrganoClick, Australian Silica Quartz, Encres Dubuit, Sansuy Industria, Suntrade Group, Cyclezyme, Berger Paints Jamaica, Sinteza, POLYDUCT Plastic and Tribox Group.

Most XP Chemistries public comparables operate across Chemicals.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
OrganoClick$11M($1M)1.3x-(10.4x)-
Australian Silica Quartz------
Encres Dubuit$20M($3M)0.2x-(1.0x)-
Sansuy Industria$187M($681K)0.3x-(82.4x)-
Suntrade Group$614K($172K)12.2x-(43.4x)-
Cyclezyme$84K($148K)89.9x-(50.8x)-
Berger Paints Jamaica$21M$898K0.3x-7.2x-
Sinteza$71K$44K47.8x-77.0x-

This data is available for Pro users. Sign up to see all XP Chemistries competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About XP Chemistries

When was XP Chemistries founded?XP Chemistries was founded in 2015.
Where is XP Chemistries headquartered?XP Chemistries is headquartered in Sweden.
How many employees does XP Chemistries have?As of today, XP Chemistries has over 3 employees.
Is XP Chemistries publicly listed?Yes, XP Chemistries is a public company listed on Nasdaq Stockholm.
What is the stock symbol of XP Chemistries?XP Chemistries trades under XPC ticker.
When did XP Chemistries go public?XP Chemistries went public in 2021.
Who are competitors of XP Chemistries?XP Chemistries main competitors include OrganoClick, Australian Silica Quartz, Encres Dubuit, Sansuy Industria, Suntrade Group, Cyclezyme, Berger Paints Jamaica, Sinteza, POLYDUCT Plastic, Tribox Group.
What is the current market cap of XP Chemistries?XP Chemistries' current market cap is $6M.
What is the current revenue of XP Chemistries?XP Chemistries' last 12 months revenue is $97K.
What is the current revenue growth of XP Chemistries?XP Chemistries revenue growth (NTM/LTM) is 2668%.
What is the current EV/Revenue multiple of XP Chemistries?Current revenue multiple of XP Chemistries is 48.8x.
Is XP Chemistries profitable?No, XP Chemistries is not profitable.
What is the current EBITDA of XP Chemistries?XP Chemistries has negative EBITDA and is not profitable.
What is XP Chemistries' EBITDA margin?XP Chemistries' last 12 months EBITDA margin is (1115%).
What is the current EV/EBITDA multiple of XP Chemistries?Current EBITDA multiple of XP Chemistries is (4.4x).
How many companies XP Chemistries has acquired to date?XP Chemistries hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies XP Chemistries has invested to date?XP Chemistries hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to XP Chemistries

Lists including XP Chemistries

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial